Kimberly Wenner, MD
Dermatology · University Place, WANPI 1467442640
Payments from drug & device makers
Across 98 payments — averaging $60.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Solta Medical, A Division Of Bausch Health US, LLC$2K
- Merz North America, Inc.$1K
- AbbVie$1K
- Revance Therapeutics, Inc.$221
- Amgen$169
- Novartis$121
- plus $704 from 12 others
What the payments were for
- Consulting fees$2,20037%
- Travel & lodging$1,03717%
- Food & beverage$2,71846%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $2,200 |
| Merz North America, Inc. | 7 | $1,364 |
| AbbVie(2 entities) | 42 | $1,177 |
| Revance Therapeutics, Inc. | 4 | $221 |
| Amgen | 6 | $169 |
| Novartis | 6 | $121 |
| Galderma Laboratories, L.p. | 3 | $117 |
| Pfizer | 6 | $106 |
| Lilly USA, LLC | 6 | $101 |
| UCB, Inc. | 4 | $101 |
| Regeneron Healthcare Solutions, Inc. | 3 | $72 |
| Johnson & Johnson | 3 | $59 |
| Sientra, Inc. | 2 | $37 |
| Sanofi | 1 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $25 |
| Bristol Myers Squibb | 1 | $23 |
| LEO Pharma Inc. | 1 | $19 |
| Almirall LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$1,143
How this compares
$5,955 in reported general payments places this provider in the 75th percentile of 323 dermatology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 73 | $2,615 |
| Metronidazole | 38 | $2,225 |
| Fluorouracil | 26 | $1,343 |
| MethotrexateMethotrexate Sodium | 32 | $986 |
| Doxycycline Hyclate | 26 | $747 |
| Ketoconazole | 34 | $530 |
| Betamethasone Valerate | 13 | $438 |
| Clindamycin Phosphate | 11 | $421 |
| CiclopiroxCiclopirox Olamine | 36 | $413 |
| Triamcinolone Acetonide | 77 | $380 |
| Dutasteride | 13 | $333 |
| Minoxidil | 13 | $199 |
| ValacyclovirValacyclovir Hcl | 20 | $140 |
| Spironolactone | 11 | $118 |
| Gabapentin | 14 | $117 |
Paid to pharmacies, not to this prescriber.
Other dermatology in University Place
- Leilani TownsendUniversity Place$7K
- William WerschlerSpokane$5.1M
- Clive LiuBellevue$3.3M
- Katherine ReedSpokane$3.1M
- Morrisa BaskinWenatchee$1.1M
- Vivian ShiSeattle$1.1M
- Daniel LevyBonney Lake$541K
- Daniel SugaiBellevue$302K
- Michi ShinoharaSeattle$277K
- Andrew PaceTacoma$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.